Jan D. Beck

446 total citations · 1 hit paper
5 papers, 320 citations indexed

About

Jan D. Beck is a scholar working on Oncology, Immunology and Molecular Biology. According to data from OpenAlex, Jan D. Beck has authored 5 papers receiving a total of 320 indexed citations (citations by other indexed papers that have themselves been cited), including 5 papers in Oncology, 4 papers in Immunology and 1 paper in Molecular Biology. Recurrent topics in Jan D. Beck's work include Immunotherapy and Immune Responses (4 papers), CAR-T cell therapy research (4 papers) and Cancer Immunotherapy and Biomarkers (3 papers). Jan D. Beck is often cited by papers focused on Immunotherapy and Immune Responses (4 papers), CAR-T cell therapy research (4 papers) and Cancer Immunotherapy and Biomarkers (3 papers). Jan D. Beck collaborates with scholars based in Germany and United Kingdom. Jan D. Beck's co-authors include Mathias Vormehr, Uğur Şahin, Özlem Türeci, Nadja Salomon, Lena M. Kranz, Fulvia Vascotto, Sebastian Kreiter, Mustafa Diken, M Suchan and Daniel T. Peters and has published in prestigious journals such as Cancer Cell, Molecular Cancer and OncoImmunology.

In The Last Decade

Jan D. Beck

4 papers receiving 312 citations

Hit Papers

mRNA therapeutics in cancer immunotherapy 2021 2026 2022 2024 2021 50 100 150 200 250

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
Jan D. Beck Germany 3 241 146 100 58 35 5 320
Hayat Bähr-Mahmud Germany 6 186 0.8× 104 0.7× 107 1.1× 75 1.3× 25 0.7× 6 312
Mubeen Mosaheb United States 6 209 0.9× 129 0.9× 155 1.6× 103 1.8× 24 0.7× 8 377
Anup Y. Parikh United States 3 197 0.8× 226 1.5× 172 1.7× 33 0.6× 31 0.9× 3 336
John Zielinski United States 4 177 0.7× 236 1.6× 134 1.3× 64 1.1× 15 0.4× 5 360
Noam Levin Israel 8 238 1.0× 284 1.9× 253 2.5× 68 1.2× 27 0.8× 12 424
Faith Musenge United States 3 142 0.6× 133 0.9× 89 0.9× 44 0.8× 10 0.3× 5 232
Samantha J. Seitter United States 2 210 0.9× 265 1.8× 224 2.2× 42 0.7× 27 0.8× 3 385
Christine T. McGowan United States 3 211 0.9× 266 1.8× 226 2.3× 42 0.7× 28 0.8× 3 388
Ameya Apte United States 2 142 0.6× 132 0.9× 83 0.8× 43 0.7× 10 0.3× 3 225
Lior Stotsky‐Oterin Israel 5 222 0.9× 72 0.5× 57 0.6× 32 0.6× 23 0.7× 8 305

Countries citing papers authored by Jan D. Beck

Since Specialization
Citations

This map shows the geographic impact of Jan D. Beck's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Jan D. Beck with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Jan D. Beck more than expected).

Fields of papers citing papers by Jan D. Beck

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Jan D. Beck. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Jan D. Beck. The network helps show where Jan D. Beck may publish in the future.

Co-authorship network of co-authors of Jan D. Beck

This figure shows the co-authorship network connecting the top 25 collaborators of Jan D. Beck. A scholar is included among the top collaborators of Jan D. Beck based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Jan D. Beck. Jan D. Beck is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

5 of 5 papers shown
1.
Beck, Jan D., Mustafa Diken, M Suchan, et al.. (2024). Long-lasting mRNA-encoded interleukin-2 restores CD8+ T cell neoantigen immunity in MHC class I-deficient cancers. Cancer Cell. 42(4). 568–582.e11. 34 indexed citations
2.
Peter, Matthias, et al.. (2024). CIMT 2024: Report on the 21st Annual Meeting of the Association for Cancer Immunotherapy. Human Vaccines & Immunotherapeutics. 20(1). 2381925–2381925.
3.
Beck, Jan D., Nadja Salomon, Uğur Şahin, et al.. (2021). mRNA therapeutics in cancer immunotherapy. Molecular Cancer. 20(1). 69–69. 272 indexed citations breakdown →
4.
Beck, Jan D., et al.. (2019). CIMT 2019: report on the 17th Annual Meeting of the Association for Cancer Immunotherapy. Human Vaccines & Immunotherapeutics. 16(4). 808–815. 1 indexed citations
5.
Vormehr, Mathias, Katharina Reinhard, Jan D. Beck, et al.. (2018). A non-functional neoepitope specific CD8+ T-cell response induced by tumor derived antigen exposure in vivo. OncoImmunology. 8(3). 1553478–1553478. 13 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Rankless by CCL
2026